Increased plasma levels of tumor necrosis factor-α in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients

被引:101
|
作者
Ferreira, RC
Ianni, BM
Abel, LCJ
Buck, P
Mady, C
Kalil, J
Cunha-Neto, E
机构
[1] Univ Sao Paulo, Lab Imunol, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Sao Paulo, Div Cardiopatias Gerais, Inst Coracao, BR-05403000 Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Div Imunol Clin & Alergia, Dept Clin Med, Fac Med, BR-05403000 Sao Paulo, SP, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2003年 / 98卷 / 03期
关键词
Chagas disease cardiomyopathy; tumor necrosis factor-alpha; Trypanosoma cruzi;
D O I
10.1590/S0074-02762003000300021
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
We compared plasma tumor necrosis factor-alpha (TNF-alpha) levels among asymptomatic/"indeterminate" Chagas disease patients (ASY) and patients across the clinical spectrum of chronic Chagas disease cardiomyopathy (CCC). Idiopathic dilated cardiomyopathy (DCM) patients and normal controls (NC) were included as controls. ASY Chagas disease patients had significantly higher plasma TNF-alpha levels than NC TNF-alpha levels among severe CCC patients with significant left ventricular (LV) dysfunction were similar to those of DCM patients, showing average 2-fold higher levels than CCC patients without LV dysfunction and ASY patients, and 8-fold higher levels than NC. In Chagas disease, chronic TNF-alpha production prior to heart failure may play a role in CCC progression.
引用
收藏
页码:407 / 411
页数:5
相关论文
共 50 条
  • [1] Lack of association of tumor necrosis factor-α polymorphisms with Chagas disease in Brazilian patients
    Drigo, Sandra A.
    Cunha-Neto, Edecio
    Ianni, Barbara
    Mady, Charles
    Fae, Kellen C.
    Buck, Paula
    Kalil, Jorge
    Goldberg, Anna Carla
    IMMUNOLOGY LETTERS, 2007, 108 (01) : 109 - 111
  • [2] Tumor necrosis factor-α and cardiomyopathy
    Bristow, MR
    CIRCULATION, 1998, 97 (14) : 1340 - 1341
  • [3] Baseline plasma levels of tumor necrosis factor-α predicts response to treatment with pentoxifylline in patients with idiopathic dilated cardiomyopathy
    Skudicky, D
    Sliwa, K
    Bergemann, A
    Candy, G
    Sareli, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 190A - 191A
  • [4] Change of Tumor Necrosis Factor-α Levels in Patients with Binswanger′s Disease
    陈春富
    贾海燕
    郭述苏
    Chinese Medical Sciences Journal, 1999, (01) : 9 - 9
  • [5] Tumor necrosis factor-α-converting enzyme and tumor necrosis factor-α in human dilated cardiomyopathy
    Satoh, M
    Nakamura, M
    Saitoh, H
    Satoh, H
    Maesawa, C
    Segawa, N
    Tashiro, A
    Hiramori, K
    CIRCULATION, 1999, 99 (25) : 3260 - 3265
  • [6] Tumor necrosis factor-α polymorphism in Turkish patients with dilated cardiomyopathy
    Alikasifoglu, M
    Tokgözoglu, L
    Acil, T
    Atalar, E
    Oto, MA
    Kes, SS
    Tuncbilek, EW
    EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (02) : 161 - 163
  • [7] INCREASED PLASMA LEVELS OF TUMOR NECROSIS FACTOR-α AND INTERLEUKIN-10 IN RHEUMATIC MITRAL STENOSIS
    Chen, Mien Cheng
    Chang, Hsueh Wen
    Wu, Chiung Jen
    Yang, Cheng Hsu
    Yu, Teng Hung
    Chen, Chien Jen
    Hung, Wei Chin
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 : S26 - S26
  • [8] Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
    Scalzo, Paula
    Kuemmer, Arthur
    Cardoso, Francisco
    Teixeira, Antonio Lucio
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 216 (1-2) : 122 - 125
  • [9] Tumor necrosis factor-α levels and promoter polymorphism in patients with Kawasaki disease in Korea
    Ahn, SY
    Jang, GC
    Shin, JS
    Shin, KM
    Kim, DS
    YONSEI MEDICAL JOURNAL, 2003, 44 (06) : 1021 - 1026
  • [10] Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
    S Endo
    Y Yamada
    K Inada
    S Sato
    Critical Care, 4 (Suppl 1):